發(fā)布時(shí)間:
2022
-
11
-
24
點(diǎn)擊次數(shù):
0
所屬職位：
羅欣集團(tuán)執(zhí)行副總裁，山東區(qū)域總裁，供應(yīng)鏈中心負(fù)責(zé)人、國際業(yè)務(wù)負(fù)責(zé)人，羅欣安若維他藥業(yè)董事長
所屬公司：
山東羅欣藥業(yè)集團(tuán)股份有限公司
個(gè)人簡介：
孫博弘，山東羅欣藥業(yè)集團(tuán)股份有限公司執(zhí)行副總裁，曾任億騰生產(chǎn)運(yùn)營副總裁，羅氏制藥（上海）生產(chǎn)運(yùn)營總監(jiān)等職務(wù)，化學(xué)學(xué)士學(xué)位，交通大學(xué)EMBA，有著制藥行業(yè)超過19年的從業(yè)經(jīng)驗(yàn)，是醫(yī)藥生產(chǎn)和質(zhì)量管理領(lǐng)域的資深管理者。 他2016年5月加入羅欣，現(xiàn)就任集團(tuán)執(zhí)行副總裁，全面負(fù)責(zé)供應(yīng)鏈中心管理和國際業(yè)務(wù)，是羅欣與阿拉賓度合資公司項(xiàng)目的總負(fù)責(zé)人。帶著羅欣人傳遞健康的情懷和堅(jiān)持創(chuàng)新發(fā)展的理念，孫博弘先生帶領(lǐng)團(tuán)隊(duì)逐步開啟了羅欣的國際化征程，致力于實(shí)現(xiàn)國外已上市或是在研的優(yōu)良藥品通過羅欣平臺得以進(jìn)入中國，惠及國內(nèi)患者，成為健康的傳遞者。Samuel Sun, Executive VP of Shandong Luoxin Pharmaceutical Group Stock Co., Ltd., with more than 19 years of experience in the pharmaceutical industry, is an expert in pharmaceutical production and quality management. Before joining Luoxin, Samuel acted as the VP in charge of production and operation at Yiteng, and Senior Director in production and operation at Roche Pharmaceutical (Shanghai). Samuel joined Luoxin Group since May, 2016. He is fully responsible for the management of supply chain center and international business. Meanwhile, Samuel is also the General Manager of the joint venture company between Luoxin and Aurobindo. Committed himself to expanding the concept of “Luoxin Pharmaceutical, Source of Health”, Samuel persists in innovation and has opened up Luoxin's road to internationalization, made great efforts in introducing high-quality drug products to domestic market for further contributions to the health of all patients of China!